Table of Content

1. Introduction


2. Research & Methodology

3. Executive Summary


4. Market Dynamics

4.1 Growth Driver

4.1.1 Rising Diabetes Mellitus in an Aging Population
4.1.2 Rising prevalence of diabetes in various age groups
4.1.3 Benefits of Insulin Pump over Multiple Daily Injection
4.1.4 Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump Devices

4.2 Challenges

4.2.1 Technological advancements in insulin infusion devices
4.2.2 Blood Glucose Meter Accuracy Problem
4.2.3 Low Compliance of Glucose Monitoring & Inadequate Reimbursement for SMBG Supplies
4.2.4 Safety Issues in Insulin Pump Devices
4.2.5 Difficulties Associated with the Pump
4.2.6 Adherence


5. United Kingdom Diabetes Market


6. United Kingdom Diabetes Population

6.1 United Kingdom Diabetes Population & Forecast
6.2 Type 1 & Type 2 Diabetes Population and Forecast


7. Market Share Analysis – United Kingdom Diabetic

7.1 By Types


8. Continuous Glucose Monitoring Market (CGM) – United Kingdom Market & Users

8.1 CGM Market by Components

8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast

8.2 United Kingdom – CGM User (2011 – 2025)
8.3 CGM Reimbursement in United Kingdom


9. Blood Glucose Device (SMBG) – United Kingdom Market & Users

9.1 Market

9.1.1 Type 1 & Type 2 (Diabetes)

9.2 Test Strips Market and Forecast

9.2.1 Type 1 & Type 2 (Diabetes)

9.3 Lancet Market and Forecast

9.3.1 Type 1 & Type 2 (Diabetes)

9.4 Meter Market and Forecast

9.4.1 Type 1 & Type 2 (Diabetes)

9.5 Blood Glucose Device (SMBG) Users and Forecast

9.5.1 Type 1 & Type 2 (Diabetes)

9.6 Reimbursement of Blood Glucose Devices in United Kingdom


10. Insulin Pen – Market & User

10.1 Insulin Pen User

10.1.1 Disposable Insulin Pen Users
10.1.2 Reusable Insulin Pen Users
10.1.3 Smart Insulin Pen Users

10.2 Insulin Pen Market

10.2.1 Disposable Insulin Pen Market
10.2.2 Reusable Insulin Pen Market
10.2.3 Smart Insulin Pen Market

10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies


11. Insulin Pump - Market & Users

11.1 Insulin Pump Market & Forecast

11.1.1 Type 1 & Type 2 (Insulin Pump Market & Forecast)

11.2 Insulin Pump Users

11.2.1 Type 1 & Type 2 (Insulin Pump User & Forecast)

11.3 Differentiation Points of Insulin Pump Products in United States

11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo

11.4 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care

11.4.1 Medtronic

11.5 Insulet Corporation

11.5.1 Training Structure for New Patients - Insulet Corporation

11.6 Animas Corporation

11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)

11.7 Tandem Diabetes Care
11.8 Reimbursement Policies on Insulin Pump


12. Insulin Pen – Company Analysis

12.1 B. Braun Melsungen AG

12.1.1 Overview
12.1.2 Initiatives & Recent Developments
12.1.3 Revenue

12.2 Eli Lilly

12.2.1 Overview
12.2.2 Initiatives & Recent Developments
12.2.3 Revenue

12.3 Artsana S.p.A.,

12.3.1 Overview
12.3.2 Initiatives & Recent Developments
12.3.3 Revenue

12.4 BD

12.4.1 Overview
12.4.2 Initiatives & Recent Developments
12.4.3 Revenue

12.5 Novo Nordisk A/S

12.5.1 Overview
12.5.2 Initiatives & Recent Developments
12.5.3 Revenue

12.6 Owen Mumford Ltd.

12.6.1 Overview
12.6.2 Initiatives & Recent Developments
12.6.3 Revenue

12.7 Ypsomed AG

12.7.1 Overview
12.7.2 Initiatives & Recent Developments
12.7.3 Revenue


13. Insulin Pump – Company Analysis

13.1 Medtronic

13.1.1 Overview
13.1.2 Insulin Pump – Product Details
13.1.3 Insulin Pump – Latest Development & Trends
13.1.4 Revenue

13.2 Insulet Corporation

13.2.1 Overview
13.2.2 Insulin Pump – Product Details
13.2.3 Revenue


14. SMBG – Company Analysis

14.1 LifeScan Inc.

14.1.1 Overview
14.1.2 Revenue & Forecast

14.2 Abbott Laboratories

14.2.1 Overview
14.2.2 Abbott Laboratories SMBG Revenue & Forecast


15. CGM – Company Analysis

15.1 Dexcom Inc

15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue& Forecast

15.2 Abbott Laboratories

15.2.1 Overview
15.2.2 Recent Development

15.3 Roche

15.3.1 Overview
15.3.2 Recent Development



List of Figures



Figure 4_1: Global Ageing Population (Billion) 2015 – 2050
Figure 5_1: United Kingdom – Diabetic Market (Billion US$), 2013 – 2019
Figure 5_2: United Kingdom – Forecast for Market (Billion US$), 2020 – 2025
Figure 6_1: United Kingdom – Diabetes Population (Thousand), 2011 – 2019
Figure 6_2: United Kingdom – Forecast for Diabetes Population (Thousand), 2020 – 2025
Figure 6_3: United Kingdom – Type 1 & Type 2 Diabetes Population (Thousand), 2011 – 2019
Figure 6_4: United Kingdom – Forecast for Type 1 & Type 2 Diabetes Population (Thousand), 2020 – 2025
Figure 8_1: United Kingdom – CGM Market (Million US$), 2011 – 2019
Figure 8_2: United Kingdom – Forecast for CGM Market (Million US$), 2020 – 2025
Figure 8_3: United Kingdom – Glucose Sensor Market (Million US$), 2011 – 2019
Figure 8_4: United Kingdom – Forecast for Glucose Sensor Market (Million US$), 2020 – 2025
Figure 8_5: United Kingdom – CGM Transmitter Market (Million US$), 2011 – 2019
Figure 8_6: United Kingdom – Forecast for CGM Transmitter Market (Million US$), 2020 – 2025
Figure 8_7: United Kingdom – CGM User (Number), 2011 – 2019
Figure 8_8: United Kingdom – Forecast for CGM User (Number), 2020 – 2025
Figure 9_1: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2011 – 2019
Figure 9_2: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2020 – 2025
Figure 9_3: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Market by Type 1 & Type 2 (Million US$), 2011 – 2019
Figure 9_4: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 9_5: United Kingdom – Blood Glucose Test Strips Market (Million US$), 2011 – 2019
Figure 9_6: United Kingdom – Forecast for Blood Glucose Test Strips Market (Million US$), 2020 – 2025
Figure 9_7: United Kingdom – Blood Glucose Test Strips Market by Type 1 & Type 2 (Million US$), 2011 – 2019
Figure 9_8: United Kingdom – Forecast for Blood Glucose Test Strips Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 9_9: United Kingdom – Blood Glucose Lancet Market (Million US$), 2011 – 2019
Figure 9_10: United Kingdom – Forecast for Blood Glucose Lancet Market (Million US$), 2020 – 2025
Figure 9_11: United Kingdom – Blood Glucose Lancet Market by Type 1 & Type 2 (Million US$), 2011 – 2019
Figure 9_12: United Kingdom – Forecast for Blood Glucose Lancet Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 9_13: United Kingdom – Blood Glucose Meter Market (Million US$), 2011 – 2019
Figure 9_14: United Kingdom – Forecast for Blood Glucose Meter Market (Million US$), 2020 – 2025
Figure 9_15: United Kingdom – Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2011 – 2019
Figure 9_16: United Kingdom – Forecast for Blood Glucose Meter Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 9_17: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2011 – 2019
Figure 9_18: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Users (Thousand), 2020 – 2025
Figure 9_19: United Kingdom – Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2011 – 2019
Figure 9_20: United Kingdom – Forecast for Self-Monitoring of Blood Glucose (SMBG) Users by Type 1 & Type 2 (Thousand), 2020 – 2025
Figure 10_1: United Kingdom – Insulin Pen Users (Thousands), 2011 – 2019
Figure 10_2: United Kingdom – Forecast for Insulin Pen Users (Thousands), 2020 – 2025
Figure 10_3: United Kingdom – Disposable Insulin Pen Users (Thousands), 2011 – 2019
Figure 10_4: United Kingdom – Forecast for Disposable Insulin Pen Users (Thousands), 2020 – 2025
Figure 10_5: United Kingdom – Reusable Insulin Pen Users (Thousands), 2011 – 2019
Figure 10_6: United Kingdom – Forecast for Reusable Insulin Pen Users (Thousands), 2020 – 2025
Figure 10_7: United Kingdom – Smart Insulin Pen Users (Thousands), 2011 – 2019
Figure 10_8: United Kingdom – Forecast for Smart Insulin Pen Users (Thousands), 2020 – 2025
Figure 10_9: United Kingdom – Insulin Pen Market (Million US$), 2011 – 2019
Figure 10_10: United Kingdom – Forecast for Insulin Pen Market (Million US$), 2020 – 2025
Figure 10_11: United Kingdom – Disposable Insulin Pen Market (Million US$), 2011 – 2019
Figure 10_12: United Kingdom – Forecast for Disposable Insulin Pen Market (Million US$), 2020 – 2025
Figure 10_13: United Kingdom – Reusable Insulin Pen Market (Million US$), 2011 – 2019
Figure 10_14: United Kingdom – Forecast for Reusable Insulin Pen Market (Million US$), 2020 – 2025
Figure 10_15: United Kingdom – Smart Insulin Pen Market (Million US$), 2011 – 2019
Figure 10_16: United Kingdom – Forecast for Smart Insulin Pen Market (Million US$), 2020 – 2025
Figure 10_17: United Kingdom – Insulin Pen Needle Market (Million US$), 2011 – 2019
Figure 10_18: United Kingdom – Forecast for Insulin Pen Needle Market (Million US$), 2020 – 2025
Figure 11_1: United Kingdom – Insulin Pump Market (Million US$), 2011 – 2019
Figure 11_2: United Kingdom – Forecast for Insulin Pump Market (Million US$), 2020 – 2025
Figure 11_3: United Kingdom – Insulin Pump Market by Type 1 & Type 2 (Million US$), 2011 – 2019
Figure 11_4: United Kingdom – Forecast for Insulin Pump Market by Type 1 & Type 2 (Million US$), 2020 – 2025
Figure 11_5: United Kingdom – Insulin Pump Users (Number), 2011 – 2019
Figure 11_6: United Kingdom – Forecast for Insulin Pump Users (Number), 2020 – 2025
Figure 11_7: United Kingdom – Insulin Pump Users by Type 1 & Type 2 (Number), 2011 – 2019
Figure 11_8: United Kingdom – Forecast for Insulin Pump Users by Type 1 & Type 2 (Number), 2020 – 2025
Figure 12_1: Global – B. Braun Melsungen AG Revenue (Million US$), 2014 – 2019
Figure 12_2: Global – Forecast for B. Braun Melsungen AG Revenue (Million US$), 2020 – 2026
Figure 12_3: Global – Eli Lilly and Company Revenue (Million US$), 2014 – 2019
Figure 12_4: Global – Forecast for Eli Lilly and Company Revenue (Million US$), 2020 – 2026
Figure 12_5: Global – Artsana S.p.A. Revenue (Million US$), 2016 – 2019
Figure 12_6: Global – Forecast for Artsana S.p.A. Revenue (Million US$), 2020 – 2026
Figure 12_7: Global – Becton, Dickinson and Company Revenue (Million US$), 2014 – 2019
Figure 12_8: Global – Forecast for Becton, Dickinson and Company Revenue (Million US$), 2020 – 2026
Figure 12_9: Global – Novo Nordisk A/S Revenue (Million US$), 2015 – 2019
Figure 12_10: Global – Forecast for Novo Nordisk A/S Revenue (Million US$), 2020 – 2026
Figure 12_11: Global – Owen Mumford Ltd. Revenue (Million US$), 2011 – 2019
Figure 12_12: Global – Forecast for Owen Mumford Ltd. Revenue (Million US$), 2020 – 2026
Figure 12_13: Global – Ypsomed AG Revenue (Million US$), 2013 – 2019
Figure 12_14: Global – Forecast for Ypsomed AG Revenue (Million US$), 2020 – 2026
Figure 13_1: Global – Medtronic Insulin Pump Revenue (Million US$), 2014 – 2019
Figure 13_2: Global – Forecast for Medtronic Insulin Pump Revenue (Million US$), 2019 – 2025
Figure 13_3: Global – Insulet Corporation Insulin Pump Revenue (Million US$), 2014 – 2019
Figure 13_4: Global – Forecast for Insulet Corporation Insulin Pump Revenue (Million US$), 2020 – 2025
Figure 14_1: Global – LifeScan SMBG Revenue (Million US$), 2014 – 2019
Figure 14_2: Global – Forecast for LifeScan SMBG Revenue (Million US$), 2020 – 2025
Figure 14_3: Global – Abbott Laboratories Diabetes Care Revenue (Million US$), 2014 – 2019
Figure 14_4: Global – Forecast for Abbott Laboratories Diabetes Care Revenue (Million US$), 2020 – 2025
Figure 15_1: Global – Dexcom Revenue (Million US$), 2014 – 2019
Figure 15_2: Global – Forecast for Dexcom Revenue (Million US$), 2020 – 2025


List of Tables


List of Tables:

Table 7_1: United Kingdom – Diabetic Market Share by Types (Percent), 2013 – 2019
Table 7_2: United Kingdom – Forecast for Diabetic Market Share by Types (Percent), 2020 – 2025
Table 11_1: United Kingdom – Animas Vibe Differentiation Features
Table 11_2: United Kingdom – Medtronic 530G with Enlite Differentiation Features
Table 11_3: United Kingdom – Insulet OmniPod Differentiation Features
Table 11_4: United Kingdom – Tandem t: slim Differentiation Features
Table 11_5: United Kingdom – Roche Accu-Chek Combo Differentiation Features
Table 13_1: Medtronic – Latest Insulin Pump Products
Table 13_2: Acquisitions by Medtronic
Table 13_3: Insulet Corporation – Latest Products
Table 14_1: Acquisitions by Abbott